← Back to guidelines
Cardiology50 papers

Benign hemangioma

Last edited: 4/14/2026

Overview

Benign hemangiomas are common vascular tumors predominantly seen in infants, typically presenting within the first few weeks of life. They often involve the head and neck region but can occur in other areas including the lumbosacral region and internal organs 12345.

Diagnosis

  • Clinical Presentation: Usually presents as a bright red or purple, soft, compressible mass 12.
  • Location: Commonly found in the head and neck; less frequent in lumbosacral and perineal regions 2.
  • Imaging: Ultrasound, MRI, or CT scans can help assess extent and involvement of deeper structures 145.
  • Differential Diagnosis: Includes pyogenic granulomas, kaposiform hemangioendothelioma, and other vascular anomalies 1.
  • Management

  • First-Line Treatment: Observation is often sufficient for uncomplicated infantile hemangiomas 1.
  • Topical Timolol: Well-tolerated and effective for superficial hemangiomas, promoting vasoconstriction and potentially aiding in regression 1.
  • Systemic Therapy: Oral corticosteroids or interferon alfa may be considered for rapidly growing or ulcerated lesions 1.
  • Surgical Intervention: Reserved for complications such as severe bleeding, ulceration, or functional impairment 1.
  • Special Populations

  • Pediatrics: Infants are the primary population affected, with extensive lesions occasionally associated with congenital anomalies 2.
  • Pregnancy: Antenatal diagnosis of fetal hemangiolymphangioma is critical for management planning 3.
  • Comorbidities: Cases involving multiple organ systems (e.g., mediastinum, spleen, kidney, liver) require multidisciplinary care 45.
  • Key Recommendations

  • Observe uncomplicated infantile hemangiomas initially (Evidence: Moderate 1).
  • Consider topical timolol for superficial hemangiomas to promote regression (Evidence: Moderate 1).
  • Evaluate and manage complications such as ulceration or functional impairment with systemic therapy or surgery (Evidence: Expert opinion 1).
  • References

    1 Alzaid M, Al-Naseem A, Al-Niaimi F, Ali FR. Topical timolol in dermatology: infantile haemangiomas and beyond. Clinical and experimental dermatology 2022. link 2 Yadav DK, Panda SS, Teckchandani N, Bagga D. SACRAL syndrome. BMJ case reports 2013. link 3 Shah KD, Chervenak FA, Marchevsky AM, Rosenberg JC, Berkowitz RL. Fetal giant hemangiolymphangioma: report of a case. American journal of perinatology 1987. link 4 Kissin MW. Mediastinal cavernous haemangioma. British journal of diseases of the chest 1977. link90112-7) 5 Kings GL. Multifocal haemangiomatous malformation: a case report. Thorax 1975. link

    Original source

    1. [1]
      Topical timolol in dermatology: infantile haemangiomas and beyond.Alzaid M, Al-Naseem A, Al-Niaimi F, Ali FR Clinical and experimental dermatology (2022)
    2. [2]
      SACRAL syndrome.Yadav DK, Panda SS, Teckchandani N, Bagga D BMJ case reports (2013)
    3. [3]
      Fetal giant hemangiolymphangioma: report of a case.Shah KD, Chervenak FA, Marchevsky AM, Rosenberg JC, Berkowitz RL American journal of perinatology (1987)
    4. [4]
      Mediastinal cavernous haemangioma.Kissin MW British journal of diseases of the chest (1977)
    5. [5]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG